INNOVATIVE EYEWEAR, INC. Revenue
INNOVATIVE EYEWEAR, INC. (LUCY) reported Revenue of $1.01 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-14
- INNOVATIVE EYEWEAR, INC. revenues for the quarter ending 2026-06-30 was $1.01M, a 74.46% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. revenues for the quarter ending 2026-03-31 was $773.56K, a 70.20% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. revenues for the quarter ending 2025-12-31 was $959.81K, a 38.96% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. revenues for the quarter ending 2025-09-30 was $668.13K, a 163.46% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. revenues for fiscal 2025 was $2.66M, a 62.65% increase from fiscal 2024.
- INNOVATIVE EYEWEAR, INC. revenues for fiscal 2024 was $1.64M, a 41.99% increase from fiscal 2023.
- INNOVATIVE EYEWEAR, INC. revenues for fiscal 2023 was $1.15M, a 74.67% increase from fiscal 2022.
- INNOVATIVE EYEWEAR, INC. revenues for fiscal 2022 was $659.79K, a 4.47% decline from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.01M 10-Q · filed 2026-08-14 | $1.78M 10-Q · filed 2026-08-14 | $2.74M derived: sum of 3 quarters · filed 2026-08-14 | $3.41M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $773.56K 10-Q · filed 2026-05-14 | $1.73M derived: sum of 2 quarters · filed 2026-05-14 | $2.40M derived: sum of 3 quarters · filed 2026-05-14 | $2.98M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $959.81K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.63M derived: sum of 2 quarters · filed 2026-03-25 | $2.21M derived: sum of 3 quarters · filed 2026-08-14 | $2.66M 10-K · filed 2026-03-25 |
| 2025-09-30 | $668.13K 10-Q · filed 2025-11-13 | $1.25M derived: sum of 2 quarters · filed 2026-08-14 | $1.70M 10-Q · filed 2025-11-13 | $2.39M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $579.23K 10-Q · filed 2026-08-14 | $1.03M 10-Q · filed 2026-08-14 | $1.72M derived: sum of 3 quarters · filed 2026-08-14 | $1.98M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $454.50K 10-Q · filed 2026-05-14 | $1.15M derived: sum of 2 quarters · filed 2026-05-14 | $1.40M derived: sum of 3 quarters · filed 2026-05-14 | $1.71M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $690.69K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $944.29K derived: sum of 2 quarters · filed 2026-03-25 | $1.25M derived: sum of 3 quarters · filed 2026-03-25 | $1.64M 10-K · filed 2026-03-25 |
| 2024-09-30 | $253.60K 10-Q · filed 2025-11-13 | $562.28K derived: sum of 2 quarters · filed 2025-11-13 | $945.75K 10-Q · filed 2025-11-13 | $1.56M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $308.68K 10-Q · filed 2025-08-14 | $692.15K 10-Q · filed 2025-08-14 | $1.31M derived: sum of 3 quarters · filed 2025-08-14 | $1.53M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $383.47K 10-Q · filed 2025-05-13 | $999.23K derived: sum of 2 quarters · filed 2025-05-13 | $1.22M derived: sum of 3 quarters · filed 2025-05-13 | $1.39M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $615.75K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $837.63K derived: sum of 2 quarters · filed 2025-03-24 | $1.01M derived: sum of 3 quarters · filed 2025-03-24 | $1.15M 10-K · filed 2025-03-24 |
| 2023-09-30 | $221.88K 10-Q · filed 2024-11-12 | $391.80K derived: sum of 2 quarters · filed 2024-11-12 | $536.73K 10-Q · filed 2024-11-12 | $603.79K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $169.93K 10-Q · filed 2024-08-12 | $314.85K 10-Q · filed 2024-08-12 | $381.92K derived: sum of 3 quarters · filed 2024-08-12 | $533.88K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $144.92K 10-Q · filed 2024-05-14 | $211.99K derived: sum of 2 quarters · filed 2024-05-14 | $363.95K derived: sum of 3 quarters · filed 2024-05-14 | $568.69K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $67.07K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $219.03K derived: sum of 2 quarters · filed 2024-03-25 | $423.77K derived: sum of 3 quarters · filed 2024-03-25 | $659.79K 10-K · filed 2024-03-25 |
| 2022-09-30 | $151.96K 10-Q · filed 2023-11-14 | $356.70K derived: sum of 2 quarters · filed 2023-11-14 | $592.72K 10-Q · filed 2023-11-14 | $868.21K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $204.74K 10-Q · filed 2023-08-11 | $440.76K 10-Q · filed 2023-08-11 | $716.25K derived: sum of 3 quarters · filed 2023-08-11 | $887.28K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $236.02K 10-Q · filed 2023-05-12 | $511.51K derived: sum of 2 quarters · filed 2023-05-12 | $682.54K derived: sum of 3 quarters · filed 2023-05-12 | $809.57K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $275.49K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $446.52K derived: sum of 2 quarters · filed 2023-03-24 | $573.54K derived: sum of 3 quarters · filed 2023-03-24 | $690.67K 10-K · filed 2023-03-24 |
| 2021-09-30 | $171.03K 10-Q · filed 2022-11-10 | $298.06K derived: sum of 2 quarters · filed 2022-11-10 | $415.19K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $127.03K 10-Q · filed 2022-09-26 | $244.15K 10-Q · filed 2022-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |